Anti–TNF-a agents have been widely used in Crohn’s disease and other autoimmune-mediated inflammatory diseases, such as rheumatoid and psoriatic arthritis, psoriasis, and ankylosing spondylitis [36]. Here, TNF is linked to ankylosing spondylitis.